Man Group PLC Fate Therapeutics Inc Transaction History

Man Group PLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$1.65 - $3.94 $56,880 - $135,823	34,473 Added 15.8%	252,676 $945,000
Q3 2023 Nov 14, 2023	BUY	$2.02 - $5.04 $89,411 - $223,085	44,263 Added 25.45%	218,203 $462,000
Q2 2023 Aug 14, 2023	BUY	$4.76 - $6.59 $489,927 - $678,282	102,926 Added 144.94%	173,940 $827,000
Q1 2023 May 15, 2023	SELL	$4.24 - $11.12 $96,769 - $253,791	-22,823 Reduced 24.32%	71,014 $404,000
Q4 2022 Feb 14, 2023	BUY	$9.86 - $23.83 $754,654 - $1.82 Million	76,537 Added 442.41%	93,837 $946,000
Q3 2022 Nov 14, 2022	BUY	$21.04 - $36.06 $363,992 - $623,838	17,300 New	17,300 $388,000
Q1 2022 May 16, 2022	SELL	$29.67 - $60.28 $368,798 - $749,280	-12,430 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$47.84 - $64.34 $594,651 - $799,746	12,430 New	12,430 $727,000
Q2 2021 Aug 16, 2021	SELL	$67.25 - $92.52 $417,757 - $574,734	-6,212 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$72.16 - $117.4 $5.28 Million - $8.58 Million	-73,111 Reduced 92.17%	6,212 $512,000
Q4 2020 Feb 16, 2021	SELL	$38.09 - $100.95 $989,463 - $2.62 Million	-25,977 Reduced 24.67%	79,323 $7.21 Million
Q3 2020 Nov 16, 2020	BUY	$30.41 - $40.5 $2.38 Million - $3.16 Million	78,133 Added 287.6%	105,300 $4.21 Million
Q2 2020 Aug 14, 2020	BUY	$20.21 - $35.23 $549,045 - $957,093	27,167 New	27,167 $932,000

175

115M

53.7K

Ticker FATE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,000,304
Market Cap $220M
Description
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

Stay updated on Man Group PLC with notifications on news.